A Fitbit got a reporter to see his doctor — and ultimately go under the knife. Are wearables the next wave in heart health?

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Smart healthtech wearable devices are trending but are these effective and accurate We reached out to a doctor who explained ...

Results from the single-arm trial saw 63.5% of patients able to avoid the symptoms of Atrial fibrillation over the course of ...

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, ...

Concerning management of AF ... disparities in the use of left atrial appendage occlusion devices in patients with atrial fibrillation and Cardathea to test a novel mapping system for conduction ...

Medtronic (NYSE: MDT) today reported study results highlighting AFib detection with its Linq family of insertable cardiac monitors (ICM).

The global appendage management market is set for steady growth, with its valuation expected to increase from US$ 223.9 ...

(JAMA Cardiology) Five-year results from the Amulet IDE trial suggested similar performance of the Amulet and Watchman 2.5 devices for left atrial appendage (LAA) occlusion in Afib patients.